NCT05051059

Brief Summary

Primary bone and soft tissue sarcomas are an exceptionally rare form of cancer, collectively accounting for only 1% of all malignancies diagnosed. Sarcomas often occur in the patients' extremities and treatment typically involves limb salvage surgery with bone and/or muscle resection. These surgeries often leave the patients with disfigurements, psychological trauma, and functional disabilities. Perhaps, the most difficult and life-altering decision that patients (and their parents) with primary bone sarcomas about the knee joint have to make, involves choosing the type of surgical procedure that will provide them with the outcome that meets their functional as well as aesthetic expectations. In literature, the quality of life for patients with osteosarcoma around the knee joint after three different surgical procedures, that is, amputation, endoprosthetic reconstruction and rotationplasty was evaluated. There was found that patients treated with rotationplasty showed significantly higher functional scores compared to the two other groups of patients. Also, researchers investigated the long-term quality of life after bone sarcoma surgery around the knee joint and found that, despite the functional disability, survivors were busy with work, study, relationships, and sometimes they have founded a family. Most published reports in the literature on assessment of gait in the lower-extremity sarcoma survivors were focused on bone sarcoma patients after wide resection and endoprosthetic reconstruction. To the knowledge of the investigator, there has been no published studies on gait analysis after resection of soft tissue sarcomas (STS) of the lower extremity. The rare and heterogeneous aspects of STS and the paucity of knowledge of movement strategies in these patients hinder the development of effective rehabilitation protocols for recovering movement after resection of STS in the lower limb.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Oct 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Oct 2021Dec 2026

First Submitted

Initial submission to the registry

September 9, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 21, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

5.2 years

First QC Date

September 9, 2021

Last Update Submit

March 12, 2026

Conditions

Keywords

Lower extremitiesHealth related quality of lifeFunctional outcomeLimb salvage surgery

Outcome Measures

Primary Outcomes (3)

  • Musculoskeletal Tumor Society Score (MSTS)

    To determine the physical and mental health for patients with extremity sarcoma

    Within a period of 1 year

  • Quality of Life Questionnaire C-30 (QLQ-C30)

    To measure cancer patients' physical, psychological and social functions

    Within a period of 1 year

  • Participation and Autonomy Questionnaire Questionnaire (IPAQ)

    To measure health-related physical activity

    Within a period of 1 year

Study Arms (3)

Soft tissue sarcoma of the thigh

OTHER

Patients who underwent surgical resection of a deep intramuscular soft tissue sarcoma of the thigh

Other: Functional outcomeOther: Health related quality of life (HRQoL) assessment

Control group

NO INTERVENTION

A group of healthy age-matched individuals will be identified out of an available gait lab database to compare the gait pattern with tha of the patient group

Bone or soft tissue sarcoma of the lower extremity

OTHER

Patients who underwent surgical resection of a bone or soft tissue sarcoma of the lower extremity

Other: Health related quality of life (HRQoL) assessment

Interventions

Quality of Life Questionnaire C-30 (QLQ-C30), Impact on Participation and Autonomy Questionnaire (IPAQ) and Musculoskeletal Tumor Society Score (MSTS)

Bone or soft tissue sarcoma of the lower extremitySoft tissue sarcoma of the thigh

3D-motion analysis and strength assessment

Soft tissue sarcoma of the thigh

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent limb salvage surgery for bone or soft tissue sarcoma of the lower extremity at UZ Leuven
  • to 95 years old
  • Patients should be at least one year post surgery
  • Informed consent has obtained

You may not qualify if:

  • Patients who received major prior surgery of the lower limbs or with any pathology, injury or disorder known to affect the locomotor system
  • Skeletally immature individuals
  • No informed consent has obtained

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

SarcomaBone Neoplasms

Interventions

Quality of LifeRestraint, Physical

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsNeoplasms by SiteBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Health StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthBehavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Hazem Wafa

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2021

First Posted

September 21, 2021

Study Start

October 1, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations